Effect of PF-00734200 in Subjects With Type 2 Diabetes

NCT00618007 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

289

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: PF-00734200 30 mg QD
DRUG: PF-00734200 20 mg QD
DRUG: Placebo

Sponsor

Pfizer